Ignite Creation Date:
2024-05-06 @ 8:51 AM
Last Modification Date:
2024-10-26 @ 12:06 PM
Study NCT ID:
NCT02834780
Status:
COMPLETED
Last Update Posted:
2023-11-13
First Post:
2016-07-13
Brief Title:
Phase 1 Study to Evaluate the Safety Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma
Sponsor:
H3 Biomedicine Inc
Organization:
Eisai Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-12-28
Start Date Type:
ACTUAL
Primary Completion Date:
2022-02-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-02-23
Completion Date Type:
ACTUAL
First Submit Date:
2016-07-13
First Submit QC Date:
July 13 2016
Study First Post Date:
2016-07-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2023-11-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-27
Last Update Post Date:
2023-11-13
Last Update Post Date Type:
ACTUAL